Pegylated synthetic human c-peptide
- Generic Name
- Pegylated synthetic human c-peptide
- Drug Type
- Biotech
- CAS Number
- 1350661-05-0
- Unique Ingredient Identifier
- IF95YG4W0P
Safety and Efficacy of CBX129801 in Patients With Type 1 Diabetes
- First Posted Date
- 2012-09-07
- Last Posted Date
- 2015-01-30
- Lead Sponsor
- Cebix Incorporated
- Target Recruit Count
- 250
- Registration Number
- NCT01681290
Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes
Phase 1
Completed
- Conditions
- Peripheral Diabetic NeuropathyType 1 DiabetesDiabetes Mellitus
- Interventions
- Drug: Placebo
- First Posted Date
- 2011-02-10
- Last Posted Date
- 2013-03-01
- Lead Sponsor
- Cebix Incorporated
- Target Recruit Count
- 72
- Registration Number
- NCT01293461
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath